Antisense IGF-I for Hepatocellular Carcinoma

互联网2014-02-13

801

Antisense gene therapy involves the selective inhibition of expression or function of disease-causing genes by treatment with an antisense molecules (RNA or oligodeoxynucleotides) complementary to its target nucleic acids, usually to some specific mRNA molecules or mRNA precursor molecules, at a specific site (1 ,2 ) (see also Note 1 ).

相关产品推荐

ENOX2/ENOX2蛋白Recombinant Human Ecto-NOX disulfide-thiol exchanger 2 (ENOX2)重组蛋白APK1 antigen (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) (COVA1)蛋白

￥1836

IGF1R重组蛋白|Recombinant Human IGF1R / CD221 Protein (His Tag)

￥2570

Recombinant-Human-Uncharacterized-protein-ATPAF1-AS1ATPAF1-AS1Uncharacterized protein ATPAF1-AS1 Alternative name(s): ATPAF1 antisense RNA 1 ATPAF1 antisense gene protein 1

￥10612

ENOX2/ENOX2蛋白Recombinant Human Ecto-NOX disulfide-thiol exchanger 2 (ENOX2)重组蛋白APK1 antigen Cytosolic ovarian carcinoma antigen 1 Tumor-associated hydroquinone oxidase蛋白

￥2832

YTHDF2/YTHDF2蛋白Recombinant Human YTH domain-containing family protein 2 (YTHDF2)重组蛋白DF2;CLL-associated antigen KW-14;High-glucose-regulated protein 8;Renal carcinoma antigen NY-REN-2蛋白

￥1836

关于丁香通

公司信息

个人用户

企业机构

无忧采购轻松科研

提问

扫一扫

实验小助手

扫码领资料

反馈

TOP

打开小程序